Institutions / Remedium Capital Partners, LLC

Remedium Capital Partners, LLC

CIK 2104501 · Institution · as of Jun 30, 2026
Portfolio value
$451.63M
Positions
6
As of
Jun 30, 2026

Portfolio trend

Portfolio value

$451.63M+265233.8%
$451.63M$225.90M$170.2KQ4 '25Q2 '26

Positions

6+0.0%
666Q4 '25Q2 '26

Top holdings

Jun 30, 2026
CompanyClassValueShares% of portfolio
Oruka Therapeutics, Inc.—$149.00M1,565,66133.0%
Spyre Therapeutics, Inc.—$129.99M1,464,16928.8%
Apogee Therapeutics, Inc.—$77.87M586,69117.2%
Damora Therapeutics Inc—$53.20M2,045,47311.8%
Jade Biosciences, Inc.—$35.06M1,577,7507.8%
Crescent Biopharma, Inc.—$6.50M361,2501.4%

Activity

Jun 30, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
DateActionCompanyValueShares ΔPosition afterImpact
Q2 2026
as of
Add36322Q206$50.07M+1.9M
+1597.87%
2,045,473
11.78% of portfolio
high
Q2 2026
as of
NewCrescent Biopharma, Inc.$6.50M+361K
361,250
1.44% of portfolio
medium
Q2 2026
as of
AddOruka Therapeutics, Inc.$1.26M+13K
+0.85%
1,565,661
32.99% of portfolio
low
Q2 2026
as of
AddSpyre Therapeutics, Inc.$704.7K+8K
+0.55%
1,464,169
28.78% of portfolio
low
Q2 2026
as of
AddApogee Therapeutics, Inc.$411.5K+3K
+0.53%
586,691
17.24% of portfolio
low
Q2 2026
as of
ExitCrescent Biopharma, Inc.$-4.3K-361K
-100.00%
—
low